Seeking Alpha

ThermoGenesis (KOOL) will merge with privately held TotipotentRx, a cell-based regenerative...

ThermoGenesis (KOOL) will merge with privately held TotipotentRx, a cell-based regenerative medicine company. KOOL will issue 12.491M shares worth some $18.6M to TotipotentRx. The deal is expected to close in Q4 and will be "transformative," in the words of KOOL CEO Matthew Plavan. (PR)
Comments (1)
  • yellowtailcheek
    , contributor
    Comments (50) | Send Message
     
    KOOL is back, ready for big time coming!
    16 Jul 2013, 09:38 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|